Sample | Title | Value | Rank |
GSM967852 | U87-EV human glioblastoma xenograft - Control 1 | 3.47615 | 56 |
GSM967853 | U87-EV human glioblastoma xenograft - Control 2 | 3.48066 | 58 |
GSM967854 | U87-EV human glioblastoma xenograft - Control 3 | 3.47282 | 57 |
GSM967855 | U87-EV human glioblastoma xenograft - Control 4 | 3.43275 | 58 |
GSM967856 | U87-EV human glioblastoma xenograft - Control 5 | 3.59686 | 61 |
GSM967862 | U87-EV human glioblastoma xenograft - Bevacizumab treated 1 | 3.48572 | 55 |
GSM967863 | U87-EV human glioblastoma xenograft - Bevacizumab treated 2 | 3.47136 | 55 |
GSM967864 | U87-EV human glioblastoma xenograft - Bevacizumab treated 3 | 3.45758 | 57 |
GSM967865 | U87-EV human glioblastoma xenograft - Bevacizumab treated 4 | 3.44552 | 57 |
GSM967857 | U87-EV human glioblastoma xenograft - dibenzazepine treated 1 | 3.47078 | 58 |
GSM967858 | U87-EV human glioblastoma xenograft - dibenzazepine treated 2 | 3.45736 | 57 |
GSM967859 | U87-EV human glioblastoma xenograft - dibenzazepine treated 3 | 3.45564 | 58 |
GSM967860 | U87-EV human glioblastoma xenograft - dibenzazepine treated 4 | 3.47377 | 57 |
GSM967861 | U87-EV human glioblastoma xenograft - dibenzazepine treated 5 | 3.47234 | 58 |